Nomura Asset Management Co. Ltd. Boosts Stake in STERIS plc (NYSE:STE)

Nomura Asset Management Co. Ltd. lifted its holdings in STERIS plc (NYSE:STEFree Report) by 3.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,698 shares of the medical equipment provider’s stock after purchasing an additional 952 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in STERIS were worth $5,650,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the business. Catalyst Capital Advisors LLC acquired a new position in shares of STERIS during the 3rd quarter worth about $25,000. VisionPoint Advisory Group LLC purchased a new position in shares of STERIS in the fourth quarter valued at approximately $34,000. Spire Wealth Management lifted its position in shares of STERIS by 88.0% in the fourth quarter. Spire Wealth Management now owns 203 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 95 shares in the last quarter. NBC Securities Inc. acquired a new stake in shares of STERIS in the third quarter worth approximately $50,000. Finally, AdvisorNet Financial Inc increased its position in shares of STERIS by 144.9% during the fourth quarter. AdvisorNet Financial Inc now owns 311 shares of the medical equipment provider’s stock worth $68,000 after purchasing an additional 184 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Insider Activity at STERIS

In other STERIS news, VP Renato Tamaro sold 1,154 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $231.64, for a total transaction of $267,312.56. Following the transaction, the vice president now directly owns 6,677 shares in the company, valued at $1,546,660.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other STERIS news, VP Renato Tamaro sold 1,154 shares of STERIS stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $231.64, for a total value of $267,312.56. Following the completion of the transaction, the vice president now directly owns 6,677 shares of the company’s stock, valued at approximately $1,546,660.28. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jacqueline B. Kosecoff sold 4,584 shares of the stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $231.53, for a total transaction of $1,061,333.52. The disclosure for this sale can be found here. In the last quarter, insiders sold 7,762 shares of company stock worth $1,798,477. Insiders own 0.95% of the company’s stock.

STERIS Trading Up 0.1 %

STE opened at $223.57 on Thursday. The business’s 50 day moving average price is $216.58 and its 200 day moving average price is $217.95. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.34 and a current ratio of 3.06. The stock has a market capitalization of $22.09 billion, a PE ratio of 58.53 and a beta of 0.81. STERIS plc has a one year low of $195.47 and a one year high of $254.00.

STERIS (NYSE:STEGet Free Report) last issued its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.41 by $0.17. STERIS had a return on equity of 13.73% and a net margin of 6.95%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the company earned $2.30 EPS. The company’s quarterly revenue was up 10.8% on a year-over-year basis. As a group, equities research analysts expect that STERIS plc will post 9.12 EPS for the current year.

STERIS Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 12th will be given a dividend of $0.52 per share. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.93%. STERIS’s payout ratio is currently 54.45%.

Wall Street Analysts Forecast Growth

STE has been the topic of a number of research reports. TheStreet upgraded STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. StockNews.com raised shares of STERIS from a “hold” rating to a “buy” rating in a research note on Saturday, May 11th. Stephens reissued an “overweight” rating and issued a $250.00 target price on shares of STERIS in a research note on Friday, February 9th. KeyCorp assumed coverage on STERIS in a research report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target for the company. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, May 10th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $241.60.

Get Our Latest Analysis on STERIS

STERIS Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Articles

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.